Featured Allogene Therapeutics, Inc. (ALLO) Stock Dipping in Aftermarket, Here’s Why Allogene Therapeutics, Inc. (ALLO), a clinical-stage immuno-oncology company, has dipped 32.73% and hence, ALLO stock was trading at $16.40 when